M. Szendroi et al., Limb-saving surgery, survival, and prognostic factors for osteosarcoma: The Hungarian experience, J SURG ONC, 73(2), 2000, pp. 87-94
Background and Objectives: There are many factors thought to have an influe
nce on the prognosis of osteosarcoma that have been reported in the literat
ure. Their significance, however, still remains controversial in most cases
. Experience with osteogenic sarcoma (OS) was reviewed in order to evaluate
surgical results and survival and to determine the prognostic factors.
Methods: Ninety-six patients with high-grade osteosarcoma of the extremitie
s were treated between 1986 and 1997 in the authors' institution. They were
divided into 3 groups: In group I, all 75 patients with non-metastatic OS
received intensive chemotherapy (high-dose methotrexate, doxorubicin, ifosf
amide, and cisplatin) and underwent surgery. In group II, 9 patients alread
y had metastases at the time of referral. In group III, 12 patients receive
d chemotherapy in delayed or suboptimal form.
Results and Conclusions: In group I, there were local recurrences in 3 pati
ents (7%) and metastases in 8 patients (20%) with limb-saving, whereas thes
e numbers were 1 (3%) and 14 (38%) in those who had amputation. The 5-year
disease-free survival (DFS) was 72% and 69% in the limb-saving and amputati
on groups, respectively. In groups II and III, 5-year DFS was extremely poo
r, 10% and 20% only, underlining the importance of stage and intensity of c
hemotherapy, respectively. With univariate analysis, sex, duration of sympt
oms, and radiographic appearance of OS had no prognostic value, whereas tum
or volume <60 cm(3), wide or radical surgical margin, distal location of OS
, cartilagineous ground substance <20%, and response to chemotherapy were p
ositive prognostic factors. The last 4 variables maintained their significa
nce in the multivariate Cox model as well. Age >30 years showed indirect ne
gative influence on the final outcome through enhanced intolerability to th
e drugs and less cooperability of the patients. The results on survival wit
h limb-saving surgery were well comparable with those of amputation. (C) 20
00 Wiley-Liss, Inc.